EE447 Cost Implications of Adverse Event Profiles in Second Generation Androgen Receptor Inhibitor (SGARI) Treatments for Non-Metastatic Castration Resistant Prostate Cancer (NMCRPC)
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.695
https://www.valueinhealthjournal.com/article/S1098-3015(22)00896-8/fulltext
Title :
EE447 Cost Implications of Adverse Event Profiles in Second Generation Androgen Receptor Inhibitor (SGARI) Treatments for Non-Metastatic Castration Resistant Prostate Cancer (NMCRPC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00896-8&doi=10.1016/j.jval.2022.04.695
First page :
Section Title :
Open access? :
No
Section Order :
10624